Certification in Pharmacovigilance
Duration: 2 months theory + 2 months onsite training
Key Learning Outcomes:
- Monitor drug safety data
- Risk Assessment
- Risk Minimization
- Learn Insightful data analysis
- Aggregating reports
- Hands On training on Argus
- PMS review
- Literature Search
- Analyze risk-benefit profiles
- Master global PV systems

Course highlights

2 months classroom training

2 month industry training

Award of Completion
Course outline
S. No | Topic | Duration (Hours) |
---|---|---|
1 | History of Clinical Research and Drug Development Process | 2 |
2 | Introduction to the Ethical and Regulatory Frameworks of Clinical Research | 2 |
3 | Fundamentals of Health Research and Evaluation Methods | 6 |
4 | Overview of ICH E6-ICH GCP | 10 |
5 | Overview of Pharmacovigilance principles, history, and significance. | 4 |
6 | Role of Pharmacovigilance in drug development, approval, and post-marketing surveillance | 4 |
7 | Regulatory Framework and Guidelines | 4 |
8 | Understanding global regulatory requirements and guidelines (e.g., FDA, EMA, and ICH) | 2 |
9 | Principles of adverse event (AE) and adverse drug reaction (ADR) reporting | 2 |
10 | Methods for collecting, recording, and evaluating AE/ADR data | 2 |
11 | Signal detection and management | 2 |
12 | Development and implementation of risk management plans | 2 |
13 | Medical evaluation and causality assessment of adverse reactions | 2 |
14 | Ethical considerations in Pharmacovigilance practice | 2 |
15 | Legal responsibilities and obligations related to drug safety reporting | 2 |
16 | Case Studies | 2 |
No Comments